Histopathological Subtypes and PD-L1 Expression in Primary Urethral Adenocarcinoma: A Series of 5 Cases.
Carlos Padilla-AnsalaEugenia García-FernándezPilar González-PeramatoPublished in: International journal of surgical pathology (2021)
In conclusion, some urethral adenocarcinomas may strongly express PD-L1 and thus could potentially allow the use of immunotherapy in selected cases of advanced or recurrent adenocarcinoma.